Elanco Animal Health
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Elanco Animal Health (ELAN). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Reportable Segment | $4.41B 100.0% | $4.42B 100.0% · +0.1% | $4.44B 100.0% · +0.5% | $4.72B 100.0% · +6.2% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by region
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Non-US [Member] | $1.80B 54.9% | $2.64B 55.4% · +47.0% | $2.45B 55.5% · -7.3% | $2.43B 55.1% · -0.5% | $2.40B 54.1% · -1.3% | $2.48B 52.6% · +3.2% |
| United States | $1.48B 45.1% | $2.12B 44.6% · +44.0% | $1.97B 44.5% · -7.5% | $1.98B 44.9% · +0.9% | $2.04B 45.9% · +2.7% | $2.23B 47.4% · +9.7% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by product line
| Segment | 2020 |
|---|---|
| Farm Animal | $1.84B 56.1% |
| Pet Health | $1.36B 41.5% |
| Contract Manufacturing | $80.0M 2.4% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.